
MilliporeSigma will collaborate with IPS and G-CON to offer end-to-end, turnkey, modular MAb manufacturing.
MilliporeSigma will collaborate with IPS and G-CON to offer end-to-end, turnkey, modular MAb manufacturing.
BioTek Instruments has released a second edition of its BioSpa software that now offers users a simplified but effective interface for kinetic imaging or detection workflows.
The company has completed development of a first-generation production process for its chimeric antigen receptor regulatory T cell product portfolio and is selecting a CMO for clinical supply.
Abzena has entered into a Master Services Agreement with a US biotech company to provide process development and manufacturing services to progress a novel antibody-drug conjugate (ADC) to clinical trials.
The European Medicines Agency has granted Samsung BioLogics approval to manufacture a monoclonal antibody at the company’s second facility in Songdo, Incheon, South Korea.
SGS has introduced a Sanger sequencing service at its Glasgow, United Kingdom, laboratory to support genetic stability testing and perform identity testing on cell banks, plasmids, and viral seeds/vectors.
The new 30,000-L, $150-million biologics manufacturing facility in Wuxi, China, quintuples the company’s existing manufacturing capability.
Oceasoft has updated its line of Bluetooth-enabled temperature data loggers for shipping and logistics applications.
The contract research, development, and manufacturing organization has expanded API aseptic manufacturing capacity at its Valladolid, Spain, facility.
The company will expand two of its Ohio facilities, investing approximately $145 million to support manufacturing and warehouse operations.
Lonza has entered into strategic license agreements for exclusive rights to a gene-therapy platform for developing treatments for hearing and balance disorders.
Biocad and Sothema Labs have partnered to release cancer-treating biosimilars into the North African market.
Binding Site has introduced a number of new monoclonal antibodies targeting infectious diseases, including cytomegalovirus, hepatitis (A, B, C, and D), herpes, human immunodeficiency virus (HIV), rubella, and toxoplasma.
The acquisition gives GE Healthcare access to a nanofiber-based platform purification technology that can offer improvements in biopharmaceutical productivity.
SciLog Select Go Single-Use Assemblies from Parker Hannifin uses an assortment of validated parts and assemblies to build needed devices for biopharmaceutical manufacturing.
MasterControl has added three new cloud-based analytical solutions to its MasterControl Version 11.7 software for clinical managers and regulatory/submissions professionals.
The company’s new modules offer scalable single-pass diafiltration and were exclusively showcased during its Leadership Forum series in Westborough, MA.
ADC Bio experts warn of impending problems in the ADC pipeline with millions wasted in development costs.
The company has appointed Albert Bourla, PhD, as its new COO.
Company completes first successful run of what is believed to be the largest synthesis-scale done for oligonucleotide APIs.
Alcami will manufacture clinical supply of the API for a drug candidate targeting various hematologics and solid cancers.
The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.
QuintilesIMS has changed its name to IQVIA to reflect its October 2016 merger with IMS Health.
The company has introduced two new GMP vessel streams at its API manufacturing facility in Northumberland, UK that allows it to now offer fully integrated drug substance and drug product manufacturing.
The authors of the study believe it could have significant implications for the discovery of new dermatological products for major diseases such as psoriasis.
The company has officially opened a local brand office in South Korean to support its existing business in the region.
Supply Chain Wizard has developed a set of integrated digital solutions to improve supply chain functions.
CDMO Celonic acquired a biomanufacturing facility in Heidelberg, Germany from Glycotope.
Almac Group will acquire BioClin Laboratories to expand Almac’s analytical service offerings.
The companies will collaborate to develop and manufacture Grid’s lead therapeutic candidate for the treatment of solid tumors.